VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
DYAIDyadic International, Inc.
$0.80$29M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksDYAICash Flow

Dyadic International, Inc. (DYAI) Cash Flow Statement

18Y historyFree accessUpdated daily

Persistent capital consumption is evident, with quarterly free cash flow deficits frequently exceeding $1.5M and an OCF/NI ratio often near 1.00, indicating a pure cash burn.

DYAI Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'06Dec'05Dec'04Dec'03
Cash from Operations-5.72M-5.7M-3.97M-6.73M-8.08M-11.28M-6.57M-5.78M-4.41M-2.61M-6.04M-802.67K-6.2M5.1M365.17K790.51K-7.82M-5.92M-128.49K
Operating CF Margin %--462.73%-113.72%-232.05%-275.87%-469.12%-410.41%-344%-340.2%-343.64%-1017.97%-254.24%-49.51%29.74%2.34%5.14%-49.2%-35.34%-60.82%
Operating CF Growth %-882.81%-43.46%40.91%16.79%28.32%-71.53%-13.69%-31.21%-69.1%56.82%-651.91%87.05%-221.67%1295.47%-53.81%110.12%-32.08%-4504.98%-
Net Income-7.29M-7.36M-5.81M-6.8M-9.74M-13.07M-9.33M-8.31M-5.69M-2.14M-3.61M65.79M-5.98M-428.05K1.35M-10.88M-10.51M-6.08M-190.78K
Depreciation & Amortization12.35K-24.17K000000676.64K000271.13K253.5K256.48K250.18K602.73K586.69K0
Stock-Based Compensation705.15K930.18K1.13M1.24M1.89M1.78M1.65M0467.2K643.43K624.81K1.11M984.16K806.56K1.2M01.6B00
Deferred Taxes00000000-676.64K000-890.13K-725.56K00-1.6B00
Other Non-Cash Items183.95K95.6K-46.45K-1.03M83.71K-1.18M108.91K1.4M697.42K-273.09K-359.59K-69.27M1.01M725.56K-1.24M1.89M758.33K923.91K0
Working Capital Changes674.46K660.79K754.53K-143.21K-321.17K1.19M990.08K1.13M119.94K-840.78K-2.69M1.57M-1.59M4.46M-3.04M9.53M1.34M-1.35M62.29K
Change in Receivables-762.08K-857.85K205.26K-93.13K-47.17K-13.92K1.08M218.62K-59.98K333.02K-513.47K-78.95K602.27K-36.03K-3.31M0000
Change in Inventory00000000234.68K-1.21M-1.96M1.44M-830.75K46.1K266.19K-625.52K1.23M-2.09M0
Change in Payables579.73K314.45K-180.18K-651.17K-248.13K549.56K-53.2K657.66K-195.75K207.43K-339.74K134.25K-1.01M885.93K00000
Cash from Investing866.18K82.08K-1.88M7.45M-2.37M5.22M22.12M7.71M3.33M103K-42.56M66.83M-252.61K-414.09K-103.94K-859.58K-447.95K-101.38K7.12K
Capital Expenditures000000000000-350.29K-406.07K-45.81K-519.47K-413.29K-101.38K0
CapEx % of Revenue0%-0%---0%0%----2.8%2.37%0.29%3.38%2.6%0.61%-
Acquisitions0000000000067M000-375K000
Investments-------------------
Other Investing000000003.33M-812.08K-42.56M-165.52K97.67K-8.02K-58.12K34.89K-34.66K07.12K
Cash from Financing4.94M4.96M5.85M0543.59K1.23M255.47K550.19K-2.3M-6.22M-13.12M73.88K55.74K220.57K37.07K18.99M-97.76K24.88M0
Debt Issued (Net)005.82M00000000-24.94K00000-1.01M0
Equity Issued (Net)4.94M4.96M24.25K000255.47K550.19K-2.3M-6.22M-13.19M8.07K55.74K61.38K37.07K13.44M027.39M0
Dividends Paid0000000000000000000
Share Repurchases00000000-2.3M-6.22M-13.29M00000000
Other Financing0000543.59K1.23M004.5K1.44K66.13K90.75K0159.19K05.55M-97.76K-1.5M0
Net Change in Cash335.93K-653.25K-8.28K720.76K-9.95M-4.89M15.81M2.44M-3.4M-8.47M-61.71M66.11M-6.4M4.9M298.31K18.92M-8.36M18.86M-121.37K
Free Cash Flow-5.72M-5.7M-3.97M-6.73M-8.08M-11.28M-6.57M-5.78M-4.41M-2.61M-6.04M-802.67K-6.55M4.69M319.36K271.04K-8.23M-6.02M-128.49K
FCF Margin %-192.15%-462.73%-113.72%-232.05%-275.87%-469.12%-410.41%-344%-340.2%-343.64%-1017.97%-254.24%-52.3%27.37%2.05%1.76%-51.81%-35.95%-60.82%
FCF Growth %-18.79%-43.46%40.91%16.79%28.32%-71.53%-13.69%-31.21%-69.1%56.82%-651.91%87.75%-239.67%1368.51%17.83%103.29%-36.72%-4583.88%-
FCF per Share-0.16-0.17-0.14-0.23-0.28-0.41-0.24-0.21-0.16-0.09-0.17-0.02-0.190.140.010.01-0.37-0.37-0.03
FCF Conversion (FCF/Net Income)0.78x0.77x0.68x0.99x0.83x0.86x0.71x0.70x0.77x1.22x1.67x-0.01x1.04x-11.90x0.27x-0.07x0.74x0.97x0.67x
Interest Paid0000000000909835.21K0000000
Taxes Paid000000000011.5K1.31M0000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Limited operational cash runway

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality Obscured by Losses

Based on the provided quarterly cash flow statements, the company's operating cash flow consistently mirrors net losses, with OCF/NI ratios frequently approaching 1.00, which suggests that the reported net income is not being distorted by significant non-cash accruals but rather reflects a pure cash burn.

The tight correlation between net income and operating cash flow indicates that the company lacks meaningful non-cash expenses to buffer its bottom line. This suggests that the reported losses are essentially cash-based, leaving little room for operational efficiency improvements without a fundamental change in the revenue model.

Persistent Free Cash Flow Deficits

As reported in financial statements, the company has maintained a negative free cash flow trajectory across all observed periods, with quarterly outflows frequently exceeding $1.5M, indicating that the business remains in a state of sustained capital consumption without any clear path to self-funding operations.

The absence of positive free cash flow suggests that the company's R&D-heavy business model is currently unable to generate sufficient returns to cover its own operating costs. Investors should monitor whether the ongoing clinical validation efforts can eventually translate into milestone payments that might stabilize this negative trend.

Working Capital Volatility Impacts Liquidity

According to recent SEC filings, working capital changes have been highly erratic, swinging from a $1.3M inflow in 2025Q2 to a $415K outflow in 2025Q4, which suggests that the company's cash position is heavily dependent on the timing of client payments and project-related payables.

This volatility in working capital highlights the transactional nature of the company's revenue, where cash inflows are tied to specific project milestones rather than a steady operational cycle. Such fluctuations may complicate short-term liquidity management, especially given the company's limited cash reserves.

SBC Masks True Cash Burn

Based on the reported figures, stock-based compensation consistently adds back hundreds of thousands of dollars to the cash flow statement each quarter, which suggests that the company is utilizing equity to preserve cash while simultaneously diluting shareholders to fund its ongoing research and development activities.

While SBC is a non-cash expense, its consistent presence indicates that the company is effectively paying for talent with equity rather than cash. This practice may be necessary for survival, but it warrants further investigation into the long-term impact on share count and the true cost of operations.

DYAI — Frequently Asked Questions

Quick answers to the most common questions about buying DYAI stock.

How much cash does Dyadic International, Inc. (DYAI) generate from operations?

Dyadic International, Inc. (DYAI) generated $-5.7M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Dyadic International, Inc.'s free cash flow?

Dyadic International, Inc. (DYAI) reported negative free cash flow of $5.7M in 2025, indicating capital requirements exceeded cash from operations.

What is Dyadic International, Inc.'s capital expenditure (CapEx)?

Dyadic International, Inc. (DYAI) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.